Search results
Found 7360 matches for
Enara Bio, a start-up located in the University’s BioEsclator, has announced a strategic collaboration and licensing agreement with Boehringer Ingelheim, worth over €876M (£787M), to lead the discovery and validation of Dark Antigens to target lung and gastrointestinal cancers.
Population, Global, and Public Health
Population and global health research generates evidence that reliably answers important questions about human health.